Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 7/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 6/20 | 1.00 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.54 |
| ▸ | PDE4A | P27815 | 3/20 | 0.50 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.50 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.50 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.50 |
| ▸ | JAK2 | O60674 | 3/20 | 0.44 |
| ▸ | JAK1 | P23458 | 3/20 | 0.44 |
| ▸ | JAK3 | P52333 | 3/20 | 0.44 |
| ▸ | RGS12 | O14924 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27543834 | 0.98 | ADORA2B (0.97) | ADORA2BADORA3ADORA2APDE4APDE4B | |
| SCHEMBL24700886 | 0.88 | ADORA2B (0.79) | ADORA2BADORA3ADORA2APDE4APDE4B | |
| SCHEMBL10441216 | 0.82 | ADORA2B (0.69) | ADORA2BADORA3ADORA2APDE4APDE4B | |
| SCHEMBL5935784 | 0.76 | ADORA3 (0.61) | ADORA2BADORA3ADORA2APDE4APDE4B | |
| SCHEMBL7295708 | 0.75 | ADORA2A (0.61) | ADORA2BADORA3ADORA2APDE4APDE4B | |
| SCHEMBL7295604 | 0.74 | ADORA2A (0.59) | ADORA2BADORA3ADORA2APDE4APDE4B | |
| SCHEMBL7022545 | 0.73 | ADORA2B (0.57) | ADORA2BADORA3ADORA2APDE4APDE4B | |
| SCHEMBL10973378 | 0.73 | ADORA3 (0.57) | ADORA2BADORA3ADORA2APDE4APDE4B | |
| SCHEMBL7296248 | 0.72 | ADORA2A (0.61) | ADORA2BADORA3ADORA2APDE4APDE4B | |
| SCHEMBL20432536 | 0.72 | ADORA2B (0.55) | ADORA2BADORA3ADORA2APDE4APDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024168301-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | FUNCTION ONCOLOGY, INC. (US) | 2024-08-15 | — | — | WO | disclosed |
| US-20150148256-A1 | BIOLUMINESCENCE IMAGING-BASED SCREENING ASSAY AND INHIBITORS OF ABCG2 | THE JOHNS HOPKINS UNIVERSITY (US) | 2015-05-28 | — | — | US | disclosed |
| US-20110250129-A1 | BIOLUMINESCENCE IMAGING-BASED SCREENING ASSAY AND INHIBITORS OF ABCG2 | THE JOHNS HOPKINS UNIVERSITY (US) | 2011-10-13 | — | — | US | disclosed |
| US-6680052-B1 | Methods of inhibiting tumor growth using adenosine receptor activated cells | ENDACEA, INC. | 2004-01-20 | — | — | US | disclosed |
| EP-1368365-A2 | C2,5'-DISUBSTITUTED AND N6,C2,5'-TRISUBSTITUTED ADENOSINE DERIVATIVES AND THEIR DIFFERENT USES | Universiteit Leiden (NL) | 2003-12-10 | — | — | EP | disclosed |
| EP-1368364-A1 | C2, 8-DISUBSTITUTED ADENOSINE DERIVATIVES AND THEIR DIFFERENT USES | Universiteit Leiden (NL) | 2003-12-10 | — | — | EP | disclosed |
| WO-2002070532-A2 | C2,5'-DISUBSTITUTED AND N6,C2,5'-TRISUBSTITUTED ADENOSINE DERIVATIVES AND THEIR DIFFERENT USES | UNIVERSITEIT LEIDEN (NL) | 2002-09-12 | — | — | WO | disclosed |
| WO-2002070534-A1 | C2, 8-DISUBSTITUTED ADENOSINE DERIVATIVES AND THEIR DIFFERENT USES | UNIVERSITEIT LEIDEN (NL) | 2002-09-12 | — | — | WO | disclosed |
| EP-1043928-A4 | METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING TUMORS USING ADENOSINE RECEPTOR ACTIVATED CELLS | LINK TECHNOLOGY INC (US) | 2001-01-17 | — | — | EP | disclosed |
| EP-1043928-A1 | METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING TUMORS USING ADENOSINE RECEPTOR ACTIVATED CELLS | Link Technology, Inc. (US) | 2000-10-18 | — | — | EP | disclosed |
| US-6074842-A | AMINO ACID AND NUCLEOTIDE SEQUENCES OF HUMAN PROTEIN USEFUL AS MARKERS TO DISTINGUISH ADIPOCYTES FROM NON-ADIPOCYTE, PATHOPHYSIOLOGICALLY LIPID-LADEN CELLS; FOR PROBES AND ANTIBODIES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2000-06-13 | — | — | US | disclosed |
| EP-0814810-A4 | ADENOSINE AS A POSITIVE INOTROP IN THE COMPROMISED HEART | UNIV MASSACHUSETTS MEDICAL (US) | 1999-06-09 | — | — | EP | disclosed |
| WO-1998019541-A1 | METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING TUMORS USING ADENOSINE RECEPTOR ACTIVATED CELLS | LINK TECHNOLOGY, INC. (US) | 1998-05-14 | — | — | WO | disclosed |
| EP-0814810-A1 | ADENOSINE AS A POSITIVE INOTROP IN THE COMPROMISED HEART | UNIVERSITY OF MASSACHUSETTS MEDICAL CENTER (US) | 1998-01-07 | — | — | EP | disclosed |
| US-5585462-A | Cloning of perilipin proteins | UNITED STATES OF AMERICA (US) | 1996-12-17 | — | — | US | disclosed |
| WO-1996028163-A1 | ADENOSINE AS A POSITIVE INOTROP IN THE COMPROMISED HEART | UNIVERSITY OF MASSACHUSETTS MEDICAL CENTER (US) | 1996-09-19 | — | — | WO | disclosed |
| US-5498605-A | ANTIISCHEMIC AGENTS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-03-12 | — | — | US | disclosed |
| WO-1994002497-A1 | SULFO-DERIVATIVES OF ADENOSINE | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-02-03 | — | — | WO | disclosed |
| WO-1992022638-A1 | PERILIPIN | THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 1992-12-23 | — | — | WO | disclosed |